Vimarsana
Biggest News Aggregation in the World

Steven Abramowitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven Abramowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Abramowitz Today - Breaking & Trending Today

MedStar Washington Hospital Center - Vimarsana News

MedStar Washington Hospital Center

MedStar Washington Hospital CenterNews, press releases, and expert sources for journalists in science, medicine & business

DC doctor is first in the world to use new treatment for deep vein thrombosis - Vimarsana News

DC doctor is first in the world to use new treatment for deep vein thrombosis

Dr. Steven Abramowitz, chairman of vascular surgery for MedStar Health, told WTOP that until now, vascular surgeons had few options to remove clots from venous stents placed in deep veins in the body.

Source: wtop.com
Inari Medical launches RevCore, Triever16 Curve catheters - Vimarsana News

Inari Medical launches RevCore, Triever16 Curve catheters

Inari Medical today announced it launched two new catheters for venous stent thrombosis and venous thromboembolism.

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis - Vimarsana News

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

IRVINE, Calif., Jan. 12, 2023 -- Inari Medical, Inc. a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced... | January 12, 2023

Inari Medical enrolls first patient in ClotTriever trial - Vimarsana News

Inari Medical enrolls first patient in ClotTriever trial

Inari Medical (Nasdaq:NARI) today announced that it enrolled the first patient in its Defiance trial for evaluating the ClotTriever system.